NCT00581503

Brief Summary

This study has been designed to utilize already obtained biopsy specimens for investigation of the utility of a new, non-invasive optical diagnostic technique. The study will allow a careful correlation between the Optical coherence tomography findings and conventional histology.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2007

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2007

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2007

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

11.3 years

First QC Date

December 19, 2007

Last Update Submit

October 19, 2022

Conditions

Lung CancerPleural CancerProstate Cancer

Keywords

early detection of lung and pleural cancerearly detection of prostate cancer

Outcome Measures

Primary Outcomes (1)

  • Pathology results.

    30 minutes

Study Arms (1)

diagnostic

oct imaging

Device: diagnostic

Interventions

diagnosticDEVICE

oct imaging

diagnostic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study Population will be identified at UCIMC, who is scheduled for prostatectomy, endobronchial, transbronchial, and pleural biopsy will be recurited to participate in the study.

You may qualify if:

  • Adult 18 years and older
  • Having procedure of endobronchial, transbronchial, and / or pleural biopsy

You may not qualify if:

  • Currently participating in any other investigational drug or device evaluation.
  • Currently taking drugs that are sensitive to light.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pulmonary and Critical Care Medicine, UCI Medical Center

Orange, California, 92868, United States

Location

Urology department, UCI Medical Center

Orange, California, 92868, United States

Location

MeSH Terms

Conditions

Lung NeoplasmsProstatic Neoplasms

Interventions

Diagnosis

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Matthew Brenner, M.D

    Beckman Laser Institute

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Matthew Brenner, M.D.,Department of Pulmonary and Critical Care Medicine

Study Record Dates

First Submitted

December 19, 2007

First Posted

December 27, 2007

Study Start

March 1, 2007

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations

US(2)